I. Xynos

J. Syrios, E. Felekouras, E. Papalambros, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma.

J. Ajani, Y. Doki, L. Wyrwicz, 2022, The New England journal of medicine.

Nivolumab (NIVO) plus ipilimumab (IPI) or NIVO plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced esophageal squamous cell carcinoma (ESCC): First results of the CheckMate 648 study.

J. Ajani, Y. Doki, Jianming Xu, 2021 .

Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial.

A. Hauschild, P. Ascierto, R. Dummer, 2015, The Lancet. Oncology.

Pregabalin for Opioid-Refractory Pain in a Patient with Ankylosing Spondylitis

G. Papadimitriou, P. Ferentinos, K. Kontoangelos, 2013, Case reports in psychiatry.

The Role of γ/δ T Cell Receptor Positive Cells in Pregnancy

B. Polgár, I. Xynos, A. Barakonyi, 1999 .

The Role of T/6 T Cell Receptor Positive Cells

B. Polgár, I. Xynos, A. Barakonyi, 1999 .

Factors Influencing Survival in Stage IV Colorectal Cancer: The Influence of DNA Ploidy

A. Lazaris, E. Patsouris, C. Kosmas, 2013, ISRN gastroenterology.

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial.

Sung-Bae Kim, Y. Doki, M. Okada, 2019, The Lancet. Oncology.

Leishmaniasis, Autoimmune Rheumatic Disease, and Anti–Tumor Necrosis Factor Therapy, Europe

N. Sipsas, M. Tektonidou, I. Xynos, 2006, Emerging infectious diseases.

Prior exposure to chemotherapy: a marker of sensitivity and selection for antiangiogenic therapy in breast cancer?

C. Palmieri, D. Patten, I. Xynos, 2014, Expert review of anticancer therapy.

Impact of treatment breaks on vismodegib patient outcomes: Exploratory analysis of the STEVIE study.

A. Hauschild, P. Ascierto, R. Dummer, 2015 .

Vismodegib (VISMO), a hedgehog pathway inhibitor (HPI), in advanced basal cell carcinoma (aBCC): STEVIE study primary analysis in 1215 patients (pts).

A. Hauschild, P. Ascierto, R. Dummer, 2016 .

Evaluation of DNA ploidy in relation with established prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis

A. Papalambros, A. Lazaris, E. Patsouris, 2009, BMC Cancer.

Pituitary insufficiency after infectious meningitis: a prospective study.

G. Kaltsas, N. Sipsas, I. Xynos, 2010, The Journal of clinical endocrinology and metabolism.

Predictors of survival in stage IV metastatic colorectal cancer.

A. Papalambros, A. Lazaris, J. Syrios, 2010, Anticancer research.

Three-Year Follow-Up and Response–Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3)

Sung-Bae Kim, Y. Doki, M. Okada, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

The significance of DNA image cytometry and Edmondson-Steiner grading on prognosis after curative resection of hepatocellular carcinoma.

A. Petrou, E. Felekouras, K. Tsigritis, 2011, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution.

L L Hench, J M Polak, J. Polak, 2001, Journal of biomedical materials research.

Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis.

J. Polak, L. Hench, L. Buttery, 2000, Biochemical and biophysical research communications.

Pancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: case report

J. Syrios, N. Tsavaris, A. Papageorgiou, 2011, BMC gastroenterology.

The role of gamma/delta T cell receptor positive cells in pregnancy.

B. Polgár, I. Xynos, A. Barakonyi, 1999, American journal of reproductive immunology.

Palliative gastrectomy and other factors affecting overall survival in stage IV gastric adenocarcinoma patients receiving chemotherapy: a retrospective analysis.

J. Syrios, E. Felekouras, G. Zografos, 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.